Ergoteles LLC Exact Sciences Corp Transaction History

Ergoteles LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $1.77 Million - $2.68 Million	28,159 Added 717.98%	32,081 $3.01 Million
Q1 2023 May 10, 2023	SELL	$47.19 - $70.77 $700,016 - $1.05 Million	-14,834 Reduced 79.09%	3,922 $265,000
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $569,244 - $996,881	18,756 New	18,756 $928,000
Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $3.77 Million - $8.06 Million	-105,759 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $6.09 Million - $8.73 Million	105,759 New	105,759 $7.4 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $616,757 - $856,484	-8,507 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $767,671 - $1.06 Million	8,507 New	8,507 $812,000
Q2 2021 Aug 12, 2021	SELL	$93.66 - $139.27 $5.6 Million - $8.33 Million	-59,782 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$116.57 - $155.01 $6.97 Million - $9.27 Million	59,782 New	59,782 $7.88 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.